Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CONLIVA AB
AB
Active
Org 5592790470
Alderharsvägen 48
Medical specialists activities · NACE 8622
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 128K
-54% vs 2023
EBITDA margin
54.7%
-70% vs 2023
Equity ratio
97.6%
Financial strength
Net profit 2024
SEK 60K
-67% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 128K
-54%
EBITDA
SEK 70K
-70%
Net profit
SEK 60K
-67%
Total assets
SEK 638K
-6%
Equity
SEK 623K
+11%
Employees
0
—
Company information
Legal name
CONLIVA AB
Org number
5592790470
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
27 oktober 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsulttjänster inom hälso- och sjukvård
Contact
Address
Alderharsvägen 48
Email
conlivaab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Gävle
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
275
292
280
128
Staff expenses
—
−1
−0
−20
EBITDA
216
234
233
70
Depreciation & amort.
−0
—
—
—
EBIT
216
234
233
70
Net financials
—
−0
−1
6
Profit before tax
217
234
232
76
Tax
−47
−50
−48
−16
Net profit
170
184
184
60
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
303
493
682
638
Equity
195
379
563
623
Long-term debt
0
—
—
—
Short-term debt
108
114
119
15
Total debt
108
114
119
15
Financial ratios
5-year trend
EBITDA margin
54.7%
This company
15.8%
Market median
+246% vs market
2021
2024
Equity ratio
97.6%
This company
38.2%
Market median
+155% vs market
2021
2024
Return on equity
9.6%
This company
18.4%
Market median
-48% vs market
2021
2024
Net profit margin
47.0%
This company
8.1%
Market median
+480% vs market
2021
2024
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
2021
2024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
PP
Peter Poorya Rami
Deputy Board Member
2022
BR
Behrouz Rabiei
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of CONLIVA AB also hold positions in
0
other companies.
Person
Role here
Other companies
Peter Poorya Rami
Deputy Board Member
0 companies
Behrouz Rabiei
Board of Directors
0 companies